Immunotherapy of American cutaneous leishmaniasis in Venezuela during the period 1990-99

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 4, 2003, Pages 469-472

  Convit, Jacinto ^a   Ulrich, M ^a   Zerpa, O ^a   Borges, R ^a   Aranzazu, N ^a   Valera, M ^a   Villarroel, H ^a   Zapata, Z ^a   Tomedes, I ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

American cutaneous leishmaniasis; Immunotherapy; Venezuela

Indexed keywords

BCG VACCINE; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; TUBERCULIN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG HYPERSENSITIVITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOTHERAPY; LEISHMANIA; MAJOR CLINICAL STUDY; MONOTHERAPY; NONHUMAN; PROMASTIGOTE; SKIN BIOPSY; SKIN LEISHMANIASIS; SKIN ULCER; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; VENEZUELA;

ANIMALS; BCG VACCINE; HUMANS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; PROTOZOAN VACCINES; SKIN TESTS; TREATMENT FAILURE; TREATMENT OUTCOME; VACCINES, COMBINED;

LEISHMANIA MAJOR; MYCOBACTERIUM BOVIS BCG; PROTOZOA;

EID: 1642458466     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)90093-9     Document Type: Article

References (15)

1. Cabrera M. Blackwell J.M. Castes M. Trujillo D. Convit J. Shaw M.A. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients Parasite Immunology 22 2000 73-79
2. Castes M. Cabrera M. Trujillo D. Convit J. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis Journal of Clinical Microbiology 26 1988 1207-1213
3. Convit J. Castellanos P.L. Rondbn A.J. Pinardi M.E. Ulrich M. Castes M. Bloom B. Garcia L. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis Lancet 1 1987 401-404
4. Convit J. Castellanos P.L. Ulrich M. Castes M. Rondbn A. Pinardi M.E. Rodriguez N. Bloom B.R. Formica S. Valecillos L. Bretafia A. Immunotherapy of localized, intermediate and diffuse forms of American cutaneous leishmaniasis Journal of Infectious Diseases 160 1989 104-115
5. Convit J. Ulrich M. Fernández C.T. Tapia F.J. Cáceres-Dittmar G. Castés M. Rondón A.J. The clinical and immunological spectrum of American cutaneous leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 87 1993 444-448
6. Díaz N.L. Zerpa O. Ponce L.V. Convit J. Rondón A.J. Tapia F.J. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterization of the lesion Experimental Dermatology 11 2002 34-41
7. Passos V.M. Barreto S.M. Romanha A.J. Krettli A.U. Volpini A.C. Lima E Costa M.F. American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment Bulletin of the World Health Organization 78 2000 968-974
8. Pompeu M.M. Brodskyn C. Teixeira M.J. Clarencio J. Van Weyenberg J. Coelho I.C. Cardoso S.S. Barral A. Barral-Netto M. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers Infection and Immunity 69 2001 7453-7460
9. Ribeiro A.L. Drummond J.B. Volpini A.C. Andrade A.C. Passos V.M. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine Brazilian Journal of Medical and Biological Research 32 1999 297-301
10. Ribeiro-de-Jesus A. Almeida R.P. Lessa H. Bacellar O. Carvalho E.M. Cytokine profile and pathology in human leishmaniasis Brazilian Journal of Medical and Biological Research 31 1998 143-148
11. Rodríguez N. De Lima H. Aguilar C.M. Rodriguez A. Barker D.C. Convit J. Molecular epidemiology of cutaneous leishmaniasis in Venezuela Transactions of the Royal Society of Tropical Medicine and Hygiene 96 supplement 1 2002 S/105-S/109
12. Saldanha A.C. Romero G.A. Guerra C. MerchanHamann E. Macedo V. de O. Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity Revista da Sociedad Brasiliera de Medicina Tropical 33 2000 383 388 [in Portuguese]
13. Saravia N.G. Weigle K. Segura I. Giannini S.H. Pacheco R. Labrada L.A. Goncalves A. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet 336 1990 398-402
14. Tokunaga T. Yamamoto T. Yamamoto S. How BCG led to the discovery of immunostimulatory DNA Japan Journal of Infectious Diseases 52 1999 1-11
15. Ulrich M. Rodriguez V. Centeno M. Convit J. Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy Clinical and Experimental Immunology 100 1995 54-58